2Mark J,Boschen. Publication trends in individual anxiety disorders: 1980-2015. Journal of Anxiety Disorders, 2008,22 (3) : 570-575.
3Li Y, Yu Q, Ma L, et al.Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city. Maturitas,2008,61 (3) : 238- 242.
8Tangen T, Mykletun A. Depression and anxiety through the cli- macteric period: an epidemiological study (HUNT-II). J Psycho- som Obstet Gynaeco1,2008,29(2) : 125-131.
9Polisseni AF, De Aratjo DA, Polisseni F,et al. Depression and anxiety in menopausal women:associated faetors.Rev Bras Ginecol Obstet, 2009,31 (3) : 117-123.
10Michael R Phillips, Jingxuan Zhang, Qichang Shi, et al. Preva- lence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological sur- vey.The Lancet, 2009,373 (9680) : 2041-2053.
7Pellow S, Chopin P, File SE, et al.Validation ofopen: closed arm entries in an elevated plus-maze as ameasureof anxiety in the rat[J].J Neurosci Methods, 1985,14 ( 3 ) : 149-167.
8Bertoglio LJ, Carobrez AP.Previousmaze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety[J].Behav Brain Res,2000,108 ( 2 ) : 197-203.
9I Gard PR, Haigh SJ, Cambursano PT, et al.Strain differences in anxiolytie effects of losartan in the mouse[J].Pharmacol Bioehem Behav,2001,69 : 35-40.
10Cole JC, Rodgers RJ.An ethological analysis of the effects of chlordiazepoxide and bretazenil ( Ro16-6028 ) in themurine ele-vated plus-maze[J].Behav Pharmaco, 1993,4 ( 6 ) : 573-580.
